Help Guide Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse




Journal Article

Cytogenetically invisible microdeletions involving PITX2 in Rieger syndrome


Ropers,  Hans-Hilger
Dept. of Human Molecular Genetics (Head: Hans-Hilger Ropers), Max Planck Institute for Molecular Genetics, Max Planck Society;

There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available

Engenheiro, E., Saraiva, J., Carreira, I., Ramos, L., Ropers, H.-H., Silva, E., et al. (2007). Cytogenetically invisible microdeletions involving PITX2 in Rieger syndrome. Clinical Genetics: an International Journal of Genetics in Medicine, 72(5), 464-470. doi:10.1111/j.1399-0004.2007.00879.x.

Cite as:
Axenfeld–Rieger syndrome (ARS) is a genetically heterogeneous autosomal dominant disorder mainly characterized by developmental defects of the anterior segment and extraocular anomalies. ARS shows great clinical variability and encompasses several conditions with overlapping phenotypes, including Rieger syndrome (RS). RS is characterized by developmental defects of the eyes, teeth and umbilicus, and the main causative gene is PITX2 (paired-like homeodomain transcription factor 2, or RIEG1) at 4q25. PITX2 mutations show great variety, from point mutations to microscopic or submicroscopic deletions, and apparently balanced translocations in few cases. We identified cytogenetically undetectable submicroscopic deletions at 4q25 in two unrelated patients diagnosed with RS. One patient had a t(4;17)(q25;q22)dn translocation with a deletion at the 4q breakpoint, and the other patient had an interstitial deletion of 4q25. Both deletions included only the PITX2 and ENPEP (glutamyl aminopeptidase) genes.